You are here

Takeda

Orexigen takes another body blow from ill-fated Contrave trial

Fierce Pharma

Wed, 03/9/16 - 03:40 pm

clinical trials

Hoping Vivus and Orexigen can finally kick-start their obesity meds? Don't count on it, analyst says

Fierce Pharma Marketing

Tue, 03/1/16 - 10:56 pm

Takeda-Teva JV 'could be a trendsetter' as Japan pushes for generics: analyst

Fierce Pharma

Mon, 02/8/16 - 09:33 pm

Teva Pharmaceutical

Takeda's U.K. unit brings sales force in-house to boost efforts in oncology, IBD

Fierce Pharma Marketing

Thu, 01/21/16 - 09:59 am

Takeda teams with enGene for gastrointestinal R&D

Fierce Biotech

Wed, 01/13/16 - 10:32 am

gastrointestinal

Takeda Acquires U.S. Biologics Manufacturing Facility

Yahoo

Tue, 01/5/16 - 09:26 pm

drug manufacturing

Takeda Provides Further Information about Its New Business Venture with Teva

Yahoo

Mon, 12/28/15 - 09:51 am

Teva Pharmaceutical

AstraZeneca supercharging its Asia strategy with WuXi and Takeda deals

Fierce Pharma

Wed, 12/16/15 - 03:47 pm

Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients and Growing Importance of Generic Medicines Use in Japan

Yahoo

Mon, 11/30/15 - 10:50 am

FDA approves 3rd multiple myeloma med of 2015, Takeda's Ninlaro

BioPharma Dive

Mon, 11/23/15 - 01:19 pm

Multiple Myeloma

Takeda's 'breakthrough' Velcade heir wins early FDA approval in myeloma

Fierce Biotech

Fri, 11/20/15 - 06:20 pm

Multiple Myeloma

Are Takeda's 900 Contrave reps worth it? Maybe not, analyst says

Fierce Pharma Marketing

Mon, 11/9/15 - 03:38 pm

The top 10 biopharma pipeline disasters of 2015

Fierce Biotech

Fri, 10/30/15 - 09:55 am

Takeda keeps Actos settlement ball rolling with two new resolutions

Fierce Pharma

Mon, 10/12/15 - 11:44 am

Contrave script growth snags, despite Takeda's 900-strong salesforce

Fierce Pharma Marketing

Tue, 09/29/15 - 09:16 am

Takeda gets enough takers to complete $2.3B Actos settlement

Fierce Pharma

Mon, 09/14/15 - 05:45 pm

Here's What Caused Orexigen Therapeutics to Slim Down in August

Motley Fool

Mon, 09/7/15 - 11:44 am

Orexigen Therapeutics

FDA warns of severe joint pain risk with DPP-4 diabetes drugs

Yahoo/Reuters

Fri, 08/28/15 - 05:52 pm

DPP-4 inhibitor

Boehringer Ingelheim

Takeda Actos settlement seems shaky as plaintiffs give it the sniff test

Fierce Pharma

Fri, 08/14/15 - 11:17 am

Takeda revamps commercial org to synch with R&D

Medical Marketing and Media

Thu, 06/18/15 - 06:11 pm

Pages